Special Drug Use Surveillance of Irribow in Female Patients
NCT02612649
·
clinicaltrials.gov ↗
COMPLETED
Status
793
Enrollment
INDUSTRY
Sponsor class
Conditions
Diarrhea-predominant Irritable Bowel Syndrome
Interventions
DRUG:
Ramosetron
Sponsor
Astellas Pharma Inc